Solriamfetol: First Global Approval
This article summarizes the milestones in the development of solriamfetol leading to this first approval as a treatment for excessive daytime sleepi ness associated with narcolepsy and OSA.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Hypersomnia | Narcolepsy | Obstructive Sleep Apnea | Sleep Disorders | Sleep Medicine